Natixis Advisors’s Astrana Health ASTH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $974K | Buy |
39,167
+11,545
| +42% | +$287K | ﹤0.01% | 1303 |
|
|
2025
Q1 | $857K | Buy |
27,622
+3,462
| +14% | +$107K | ﹤0.01% | 1313 |
|
|
2024
Q4 | $762K | Sell |
24,160
-3,820
| -14% | -$120K | ﹤0.01% | 1385 |
|
|
2024
Q3 | $1.62M | Buy |
27,980
+404
| +1% | +$23.4K | ﹤0.01% | 1152 |
|
|
2024
Q2 | $1.12M | Sell |
27,576
-216
| -0.8% | -$8.76K | ﹤0.01% | 1218 |
|
|
2024
Q1 | $1.17M | Buy |
27,792
+2,131
| +8% | +$89.5K | ﹤0.01% | 1171 |
|
|
2023
Q4 | $982K | Buy |
+25,661
| New | +$982K | ﹤0.01% | 1211 |
|